Free Trial

Hitesh Ramani Sells 10,000 Shares of UiPath (NYSE:PATH) Stock

UiPath logo with Computer and Technology background

Key Points

  • Hitesh Ramani, UiPath's Chief Accounting Officer, sold 10,000 shares on October 17th at an average price of $15.73, totaling $157,300, reducing his ownership by 4.49% to approximately 212,776 shares.
  • The stock is currently trading at $15.44, following a decrease of $0.49, with a market capitalization of $8.20 billion and a PE ratio of 514.77.
  • UiPath's latest quarterly earnings report showed an EPS of $0.15, exceeding analyst expectations, with revenues of $361.73 million, marking a 14.6% increase year-over-year.
  • MarketBeat previews top five stocks to own in November.

UiPath, Inc. (NYSE:PATH - Get Free Report) CAO Hitesh Ramani sold 10,000 shares of the business's stock in a transaction on Friday, October 17th. The shares were sold at an average price of $15.73, for a total transaction of $157,300.00. Following the completion of the transaction, the chief accounting officer owned 212,776 shares of the company's stock, valued at approximately $3,346,966.48. This represents a 4.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Hitesh Ramani also recently made the following trade(s):

  • On Wednesday, October 15th, Hitesh Ramani sold 10,000 shares of UiPath stock. The shares were sold at an average price of $16.68, for a total transaction of $166,800.00.
  • On Monday, October 13th, Hitesh Ramani sold 10,000 shares of UiPath stock. The shares were sold at an average price of $17.01, for a total transaction of $170,100.00.

UiPath Price Performance

NYSE PATH traded down $0.49 on Friday, hitting $15.44. The company had a trading volume of 22,881,423 shares, compared to its average volume of 14,226,154. The company has a market capitalization of $8.20 billion, a PE ratio of 514.77, a PEG ratio of 6.18 and a beta of 1.07. The company's fifty day moving average price is $12.42 and its 200-day moving average price is $12.18. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $18.74.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.08 by $0.07. The company had revenue of $361.73 million during the quarter, compared to analyst estimates of $347.36 million. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The firm's revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.04 EPS. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, sell-side analysts anticipate that UiPath, Inc. will post -0.17 EPS for the current year.

Institutional Investors Weigh In On UiPath

A number of large investors have recently modified their holdings of PATH. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of UiPath in the second quarter valued at about $28,000. AdvisorNet Financial Inc grew its holdings in shares of UiPath by 320.4% in the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock valued at $32,000 after purchasing an additional 1,887 shares during the period. GAMMA Investing LLC grew its holdings in shares of UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock valued at $38,000 after purchasing an additional 969 shares during the period. IFP Advisors Inc grew its holdings in shares of UiPath by 508.0% in the second quarter. IFP Advisors Inc now owns 3,283 shares of the company's stock valued at $42,000 after purchasing an additional 2,743 shares during the period. Finally, Brooklyn Investment Group grew its holdings in shares of UiPath by 314.3% in the first quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock valued at $46,000 after purchasing an additional 3,420 shares during the period. Hedge funds and other institutional investors own 62.50% of the company's stock.

Wall Street Analyst Weigh In

PATH has been the subject of several recent analyst reports. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a report on Friday, September 5th. Cowen reissued a "hold" rating on shares of UiPath in a report on Friday, September 5th. Wall Street Zen raised shares of UiPath from a "buy" rating to a "strong-buy" rating in a report on Saturday, September 6th. Zacks Research raised shares of UiPath from a "hold" rating to a "strong-buy" rating in a report on Monday, September 8th. Finally, DA Davidson started coverage on shares of UiPath in a report on Friday, September 5th. They set a "neutral" rating and a $12.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $13.21.

View Our Latest Analysis on PATH

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Insider Buying and Selling by Quarter for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s New Deal: Is it an Earnings Signal Investors Can’t Ignore?
From $1 to $15: The Rare Earth Stocks Powering Massive Gains
3 Undervalued Energy Stocks Under $20 with Big Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines